Syntax Research, Inc. Medtronic PLC Transaction History
Syntax Research, Inc.
- $148 Billion
- Q3 2024
A detailed history of Syntax Research, Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Syntax Research, Inc. holds 6,319 shares of MDT stock, worth $510,196. This represents 0.38% of its overall portfolio holdings.
Number of Shares
6,319
Previous 911
593.63%
Holding current value
$510,196
Previous $71.7 Million
693.39%
% of portfolio
0.38%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding MDT
# of Institutions
2,288Shares Held
1.02BCall Options Held
8.05MPut Options Held
7.19M-
Vanguard Group Inc Valley Forge, PA123MShares$9.97 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY112MShares$9.03 Billion0.2% of portfolio
-
State Street Corp Boston, MA60.7MShares$4.9 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA32.6MShares$2.63 Billion0.63% of portfolio
-
Jpmorgan Chase & CO New York, NY30.7MShares$2.48 Billion0.23% of portfolio
About Medtronic plc
- Ticker MDT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,329,149,952
- Market Cap $107B
- Description
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...